Homologous recombination deficiency (HRD) in 543 ovarian cancer samples: A single center hands-on experience

被引：0
|
作者：
Kotsakis, A. [1 ]
Konstantoulakis, P. [2 ]
Christopoulou, G. [2 ]
Samara, S. [2 ]
Oikonomaki, A. [2 ]
Roumelioti, K. [2 ]
Pachitsa, F. [2 ]
Koinis, F. [3 ]
Georgoulias, V. [4 ]
机构：
[1] Univ Gen Hosp Larissa, Dept Med Oncol, Larisa, Greece
[2] Genotypos Sci Labs, Genom, Athens, Greece
[3] Univ Hosp Larissa, Dept Med Oncol, Larisa, Greece
[4] Metropolitan Gen Hosp, Dept Med Oncol 1, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581P
引用
收藏
页码：S813 / S813
页数：1
相关论文
共 50 条
  • [41] Homologous recombination deficiency (HRD) status and response to platinum-based chemotherapy and PARP inhibitors in Chinese patients with ovarian cancer.
    Yuan, Hua
    Li, Ning
    Wu, Lingying
    Yao, Hongwen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion
    Vergote, I
    Denys, H.
    Altintas, S.
    Kerger, J.
    Baurain, J-F
    Bours, V
    Henry, S.
    Van de Vijver, K.
    Lambrechts, D.
    Gennigens, C.
    FACTS VIEWS AND VISION IN OBGYN, 2022, 14 (02): : 111 - 120
  • [43] Correlation of homologous recombination deficiency (HRD) status by BROCA-HR sequencing with response to combination cediranib and olaparib in relapsed ovarian cancer
    Liu, Joyce F.
    Cheng, Su-Chun
    Wenham, Robert M.
    Hendrickson, Andrea E. Wahner
    Armstrong, Deborah K.
    Chan, Nancy
    Cohn, David E.
    Lee, Jung-Min
    Penson, Richard T.
    Cristea, Mihaela
    Abbruzzese, James
    Matsuo, Koji
    Olawaiye, Alexander B.
    Curtis, Jennifer
    Shapiro, Geoffrey
    Matulonis, Ursula A.
    Kohn, Elise
    Ivy, Percy
    Swisher, Elizabeth M.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [44] HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD) TESTING ON CELL-FREE TUMOR DNA FROM PERITONEAL FLUID OF PATIENT WITH EPITHELIAL OVARIAN CANCER
    Roussel-Simonin, Cyril
    Blanc-Durand, Felix
    Tang, Roseline
    Vasseur, Damien
    Le Formal, Audrey
    Chardin, Laure
    Gouy, Sebastien
    Maulard, Amandine
    Scherier, Stephanie
    Sanson, Claire
    Lacroix, Ludovic
    Cotteret, Sophie
    Mauny, Lea
    Zaccarini, Francois
    Rouleau, Etienne
    Leary, Alexandra
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A32 - A32
  • [45] Homologous recombination deficiency and molecular subtype are associated with immunogenicity in ovarian cancer
    Fares, Charlene M.
    Fenerty, Kathleen E.
    Chander, Cinthiya
    Theisen, Matthew K.
    Konecny, Gottfried E.
    BIOMARKERS IN MEDICINE, 2022, 16 (10) : 771 - 782
  • [46] Use of homologous recombination deficiency (HRD) score to enrich for niraparib sensitive high grade ovarian tumors.
    Wilcoxen, Keith Matthew
    Becker, Marc
    Neff, Christopher
    Abkevich, Victor
    Jones, Joshua Timothy
    Hou, Xiaonan
    Wang, Yan
    Hartman, Anne-Renee
    AlHilli, Mariam M.
    Gutin, Alexander
    Agarwal, Shefali
    Timms, Kirsten
    Haluska, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [47] Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
    da Cunha Colombo Bonadio, Renata Rodrigues
    Fogace, Rodrigo Nogueira
    Miranda, Vanessa Costa
    Estevez Diz, Maria del Pilar
    CLINICS, 2018, 73
  • [48] RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN EARLY-STAGE OVARIAN CANCER CONSIDERING HOMOLOGOUS RECOMBINATION DEFICIENCY(HRD) STATUS
    Kim, Won-Ji
    Noh, Joseph
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Jeong-Won
    Kim, Byoung Gie
    Lee, Yoo Young
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A183 - A183
  • [49] Homologous recombination deficiency testing in first-line ovarian cancer
    Moore, K. N.
    du Bois, A.
    ANNALS OF ONCOLOGY, 2022, 33 (03) : 231 - 233
  • [50] Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer
    Vanderstichele, Adriaan
    Busschaert, Pieter
    Olbrecht, Siel
    Lambrechts, Diether
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 5 - 14
12345